Synthesis and antiparkinsonian activity of some new adamantyl thiazolidinonyl/azeti-dinonyl indole derivatives

Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry

Volumn 49, Issue 10, 2010, Pages 1398-1405

  Kumar, Sunil ^a   Kaur, Hemlata ^a   Saxena, K K ^a   Sharrna, Monica ^a   Vishwakarma, Pinki ^a   Kumar, Ashok ^a  

^a LLRM MEDICAL COLLEGE   (India)

Author keywords

Acute toxicity; Adamantly azetidinonyl indoles; Adamantylthiazolidinonyl indoles; Antiparkinsonian activity

Indexed keywords

EID: 78049287744     PISSN: 03764699     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Kumar A, Agarwal J C, Nath C, Gurtu S, Sinha J N, Bhargava K P & Shanker K, Heterocycl Chem, 18,1981,1269.
2. Hiibner H, Kraxner J & Gmeiner P, J Med Chem, 43(23), 2000 4563.
3. Kumar P, Nath C, Bhargava K P & Shanker K, Curr Sci, 52, 1983,795.
4. Ergenc N, Gursoy N S & Demirdamar R, Eur J Med Chem, 33,1998,143.
5. Siddiqui N & Ahsan M S AW, Acta Pharm, 58, 2008,445.
6. Archana, Srivastava V K & Kumar A, Eur J Med Chem, 37, 2002, 873.
7. Singer C, Papapetropoulos S, Uzcateguli G & Vela L, The J ApplRes, 6 (3), 2006,240.
8. Luginger E, Wenning G K, Bosch S & Poewe W, Mov Disord, 15, 2000, 873.
9. Severy F.Dis Nerv Syst,38,1977, 605.
10. Kumar P, Nath C, Bhargava K P & Shanker K, Indian J Chem, 21B, 1982,1128.
11. Goel R K, Singh A, Naidu P S, Mahajan M P & Kulkarni S K, J Pharm Sci, 8 (2), 2005,182.
12. Srivastava V K, Palit G, Singh S, Dhawan R & Shanker K, J Indian Chem Soc, 67,1990, 335.
13. Coward D M & Doggett N S, Psycho Pharmacol, 52 (2), 1977,165.
14. Goldstein J M, Barnett A & Malick J B, Eur J Pharmacol, 33, 1975,183.
15. Morpurgo C,Arch Int Pharmacodyn Ther, 8,1962,46.
16. Smith Q E, Pharmacological screening tests progress in Medicinal Chemistry (Butterworths, London), 1,1960,1.